170 related articles for article (PubMed ID: 20673239)
1. Maternally transferred anti-factor VIII IgG reduce the anti-factor VIII humoral immune response in factor VIII-deficient mice.
Meslier Y; André S; Teyssandier M; Kaveri SV; Lacroix-Desmazes S
Immunology; 2010 Dec; 131(4):549-55. PubMed ID: 20673239
[TBL] [Abstract][Full Text] [Related]
2. Immune response against serial infusion of factor VIII antigen through an implantable venous-access device system in haemophilia A mice.
Madoiwa S; Kobayashi E; Kashiwakura Y; Sakata A; Yasumoto A; Ohmori T; Mimuro J; Sakata Y
Haemophilia; 2012 May; 18(3):e323-30. PubMed ID: 22044430
[TBL] [Abstract][Full Text] [Related]
3. B cell-activating factor modulates the factor VIII immune response in hemophilia A.
Doshi BS; Rana J; Castaman G; Shaheen MA; Kaczmarek R; Butterfield JS; Meeks SL; Leissinger C; Biswas M; Arruda VR
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33651716
[TBL] [Abstract][Full Text] [Related]
4. A cellular viewpoint of anti-FVIII immune response in hemophilia A.
André S; Meslier Y; Dimitrov JD; Repessé Y; Kaveri SV; Lacroix-Desmazes S; Dasgupta S
Clin Rev Allergy Immunol; 2009 Oct; 37(2):105-13. PubMed ID: 19165635
[TBL] [Abstract][Full Text] [Related]
5. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
[TBL] [Abstract][Full Text] [Related]
6. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
Sahud M; Zhukov O; Mo K; Popov J; Dlott J
Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells.
Meslier Y; André S; Dimitrov JD; Delignat S; Bayry J; Kaveri SV; Lacroix-Desmazes S
J Thromb Haemost; 2011 Apr; 9(4):719-28. PubMed ID: 21251202
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates.
Di Giambattista M; Branckaert T; Hougardy V; Kemball-Cook G; Laub R
Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150
[TBL] [Abstract][Full Text] [Related]
9. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
[TBL] [Abstract][Full Text] [Related]
10. High-dose factor VIII inhibits factor VIII-specific memory B cells in hemophilia A with factor VIII inhibitors.
Hausl C; Ahmad RU; Sasgary M; Doering CB; Lollar P; Richter G; Schwarz HP; Turecek PL; Reipert BM
Blood; 2005 Nov; 106(10):3415-22. PubMed ID: 16091456
[TBL] [Abstract][Full Text] [Related]
11. Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A.
Zerra PE; Cox C; Baldwin WH; Patel SR; Arthur CM; Lollar P; Meeks SL; Stowell SR
Blood; 2017 Dec; 130(23):2559-2568. PubMed ID: 28978569
[TBL] [Abstract][Full Text] [Related]
12. Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
Lacroix-Desmazes S; Wootla B; Dasgupta S; Delignat S; Bayry J; Reinbolt J; Hoebeke J; Saenko E; Kazatchkine MD; Friboulet A; Christophe O; Nagaraja V; Kaveri SV
J Immunol; 2006 Jul; 177(2):1355-63. PubMed ID: 16818797
[TBL] [Abstract][Full Text] [Related]
13. Induction of heme oxygenase-1 in factor VIII-deficient mice reduces the immune response to therapeutic factor VIII.
Dimitrov JD; Dasgupta S; Navarrete AM; Delignat S; Repesse Y; Meslier Y; Planchais C; Teyssandier M; Motterlini R; Bayry J; Kaveri SV; Lacroix-Desmazes S
Blood; 2010 Apr; 115(13):2682-5. PubMed ID: 19890094
[TBL] [Abstract][Full Text] [Related]
14. Circulating FVIII-specific IgG, IgA and IgM memory B cells from haemophilia A patients.
Diaz I; Bolloré K; Tuaillon E; Lapalud P; Giansily-Blaizot M; Vendrell JP; Schved JF; Lavigne-Lissalde G
Haemophilia; 2016 Sep; 22(5):799-805. PubMed ID: 27439547
[TBL] [Abstract][Full Text] [Related]
15. B-cell and T-cell epitopes in anti-factor VIII immune responses.
Pratt KP; Thompson AR
Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
[TBL] [Abstract][Full Text] [Related]
16. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor.
Jacquemin MG; Desqueper BG; Benhida A; Vander Elst L; Hoylaerts MF; Bakkus M; Thielemans K; Arnout J; Peerlinck K; Gilles JG; Vermylen J; Saint-Remy JM
Blood; 1998 Jul; 92(2):496-506. PubMed ID: 9657749
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice.
Kallas A; Kuuse S; Maimets T; Pooga M
Thromb Res; 2007; 120(6):911-9. PubMed ID: 17376515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
